Dátil
Financial Software · 11-50 Employees
View Company Info for Free
Overview
Website
www.datil.coRevenue
<$5 MillionIndustry
About Dátil
Dátil Org Chart
Is Dátil your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Dátil has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Dátil recently announced quarterly report
Product Launch: Get notified when Dátil launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Dátil has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Dátil had a recent Job posting/layoffs
Check out if Dátil is spiking on competitors!
Dátil, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Dátil
Recommended Actions
Find VP level buyers at Dátil
Find more new buyers
Company Profile Activity
Activity Insights
Dátil is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Dátil is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Dátil.
Dátil Tech Stack
A closer look at the technologies used by Dátil
Most Recent Scoops
Dátil News & Media
Precision BioSciences, Inc. (DTIL) Discusses ARCUS Platform Progress and ELIMINATE-B Clinical Trial Update for Chronic Hepatitis B Transcript
Precision BioSciences, Inc. (DTIL) Discusses ARCUS Platform Progress and ELIMINATE-B Clinical Trial Update for Chronic Hepatitis B November 11, 2025 8:00 AM...Precision BioSciences, Inc. (DTIL) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript
Precision BioSciences’ ARCUS platform aims revolutionize genes for HBV and DMD.Precision BioSciences (DTIL) Stock Sinks As Market Gains: What You Should Know
Precision BioSciences (DTIL) closed at $4.28 in the latest trading session, marking a -1.83% move from the prior day.What to Expect From Precision BioSciences (DTIL) Q4 Earnings
On Precision BioSciences' (DTIL) Q4 earnings call, investor focus is likely to be on updates on the progress of the company's pipeline.
Top Financial Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dátil
Dtil is an electronic invoicing platform designed to automate billing, inventory management, and other crucial business areas for a wide range of clients, from independent professionals to large corporations. They provide authorized electronic billing services that comply with the regulatory requirements across various countries. The platform enabl... Read More